FDA
-
-
-
-
-
-
-
Sana Biotechnology publishes diabetes cell transplant data in NEJM
-
-
-
-
-
-
-
Sana Biotechnology (SANA) Announces FDA Clearance of INDA for SC262
-
-
-
-
-
-
-
Sana Biotechnology Announces the Appointment of Two Pioneers in Drug Discovery and Development to Lead its R&D Organization
-
-
-
-
-
-
-
IASO Bio and Innovent Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
-
-
-
-
-
-
-
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

